CME|Events|December 18, 2024
Rare Disease Summit (March 18-20, 2025)
Philadelphia, PA
Unite with the rare disease community to create powerful partnerships, advance orphan therapeutics and deliver life-changing breakthroughs
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Approves Hernexeos
2
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
FDA Approves Dupixent as First Treatment for Allergic Fungal Rhinosinusitis in Adults and Children
5